KALARIS THERAPEUTICS INC COM

KALARIS THERAPEUTICS INC COM is a security (CUSIP 482929106) tracked across SEC portfolio filings. 55 institutional managers reported $107.2M on Form 13F as of 2026-06-30; 3 registered fund positions totaling $454K via N-PORT as of 2026-05-29.

Summary

Top institutional holders (Form 13F)

Showing 15 of 55 managers by value.

ManagerLocationValueShares
Samsara BioCapital, LLCPalo Alto, CA$74.7M12,948,081
RTW INVESTMENTS, LPNEW YORK, NY$7.5M1,300,000
Paradigm Biocapital Advisors LPNEW YORK, NY$4.0M700,000
Alyeska Investment Group, L.P.CHICAGO, IL$3.3M572,687
Siren, L.L.C.New York, NY$2.5M435,798
VANGUARD GROUP INCValley Forge, PA$2.5M292,790
Ikarian Capital, LLCDALLAS, TX$2.1M360,000
Propel Bio Management, LLCLOS ANGELES, CA$1.7M295,771
Kalehua Capital Management LLCDALLAS, TX$782K135,585
RAYMOND JAMES FINANCIAL INCST. PETERSBURG, FL$686K118,887
GOLDMAN SACHS GROUP INCNEW YORK, NY$638K110,503
Woodline Partners LPSan Francisco, CA$577K100,000
ADAR1 Capital Management, LLCAUSTIN, TX$577K100,000
WHI TRUST Co LLCCHICAGO, IL$563K97,493
BOOTHBAY FUND MANAGEMENT, LLCNEW YORK, NY$532K92,261

Top fund holders (N-PORT)

FundRegistrantValue% of fund
VANGUARD EXTENDED MARKET INDEX FUNDVANGUARD INDEX FUNDS$419K0.05%
VANGUARD BALANCED INDEX FUNDVANGUARD VALLEY FORGE FUNDS$35K0.01%
Guggenheim Active Allocation FundGuggenheim Active Allocation Fund$370.00%

More